MSR12 Analysis of Long-Term Survivorship (LTS) Rates for Stage 2B/2C Melanoma Using Published Real-World Data (RWD) and Data From Randomized Controlled Trials (RCTS)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2071
https://www.valueinhealthjournal.com/article/S1098-3015(23)05201-4/fulltext
Title :
MSR12 Analysis of Long-Term Survivorship (LTS) Rates for Stage 2B/2C Melanoma Using Published Real-World Data (RWD) and Data From Randomized Controlled Trials (RCTS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05201-4&doi=10.1016/j.jval.2023.09.2071
First page :
Section Title :
Open access? :
No
Section Order :
11515